Voluntary Good Pharmacovigilance Practices (GVP) Inspection on Pharmaceutical Product Registration Holders (PRHs)

Kadar pengguna: 5 / 5

bintang aktifbintang aktifbintang aktifbintang aktifbintang aktif
 

The National Pharmaceutical Regulatory Agency (NPRA) will be conducting Good Pharmacovigilance Practices (GVP) Inspection on pharmaceutical product registration holders (PRHs). The implementation of the GVP Inspection will be done in phases, starting with a voluntary phase from January 2023. The main aim of the voluntary GVP Inspection is to facilitate PRHs to build and strengthen their pharmacovigilance systems and practice in accordance with the Malaysian Guidelines on GVP prior to the actual GVP Inspection in the future.

A guidance document titled "Malaysian Guidance Document on Voluntary Good Pharmacovigilance Practices (GVP) Inspection" has been prepared as a reference for PRHs who wish to join the voluntary GVP inspection.  Please refer to the guidance document for further details on the mechanism of GVP Inspection.

The voluntary GVP Inspection announcement letter and guidance document are available here.

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Profesor Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Khamis 23 Jun 2022, 15:38:02.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Choose Your Language

Menu Utama